{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:07:47Z","timestamp":1790053667430,"version":"4.0.1"},"reference-count":31,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Agency","award":["2024\/ABM\/03\/KPO\/KPOD.07.07-IW.07-0180\/24-00"],"award-info":[{"award-number":["2024\/ABM\/03\/KPO\/KPOD.07.07-IW.07-0180\/24-00"]}]},{"award":["2024\/ABM\/03\/KPO\/KPOD.07.07-IW.07-0180\/24-00"],"award-info":[{"award-number":["2024\/ABM\/03\/KPO\/KPOD.07.07-IW.07-0180\/24-00"]}],"id":[{"id":"https:\/\/ror.org\/026nedj88","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Fresh ovarian cancer tissue is a demanding starting material for cellular workflows, particularly when the aim is to obtain tumor-derived suspensions suitable for further TIL-oriented procedures. In this study, we evaluated post-isolation cell concentration and viability in ovarian cancer specimens processed according to a standardized mechanical\u2013enzymatic protocol. Methods: Biological material was collected from 24 patients undergoing routine surgery for ovarian cancer or suspected advanced ovarian malignancy. After macroscopic assessment and exclusion of extensively necrotic tissue, 19 specimens were included in the final analysis. The cohort was dominated by high-grade serous ovarian carcinoma, which accounted for 15 of 19 analyzed cases. Tissue specimens varied markedly in mass, with a median processed tissue weight of 2.05 g and a range from 0.11 to 14.93 g. Results: The median final cell concentration was 8.10 \u00d7 106 cells\/mL, with values ranging from 6.40 \u00d7 103 to 9.26 \u00d7 108 cells\/mL. Median viability was 80.8%, although individual results ranged widely from 2.3% to 98.7%. The calculated median concentration of viable cells was 6.17 \u00d7 106 viable cells\/mL. Tissue mass showed a moderate positive association with final cell concentration (Spearman\u2019s rho = 0.50, p = 0.028), but not with viability. Conclusions: These findings show that standardized processing of ovarian cancer surgical specimens can generate cell suspensions suitable for post-isolation quality assessment, even when the input material is highly variable. The present study focused on early post-isolation quality-control readouts obtained after tumor dissociation and did not evaluate TIL expansion capacity, detailed TIL phenotype, or antitumor function. The wide range of final cell concentrations underlines the biological and practical heterogeneity of ovarian cancer tissue and supports the need for careful reporting of early tissue-processing parameters in TIL-oriented workflows.<\/jats:p>","DOI":"10.3390\/cancers18183027","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:50:03Z","timestamp":1789995003000},"page":"3027","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Standardized Upstream Processing of Ovarian Cancer Surgical Specimens for TIL-Oriented Cellular Workflows"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9168-2700","authenticated-orcid":false,"given":"Anna","family":"Biernacka","sequence":"first","affiliation":[{"name":"Department of Regenerative Medicine, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2539-3894","authenticated-orcid":false,"given":"Joanna","family":"Kacperczyk-Bartnik","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"},{"name":"II Department of Obstetrics, Gynaecology and Gynaecological Oncology, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3484-416X","authenticated-orcid":false,"given":"Ewa","family":"Witkowska","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4036-0064","authenticated-orcid":false,"given":"Julia","family":"Foremniak","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Mariusz","family":"Bidzi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9406-6868","authenticated-orcid":false,"given":"Pawe\u0142","family":"Derlatka","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"},{"name":"II Department of Obstetrics, Gynaecology and Gynaecological Oncology, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9660-7496","authenticated-orcid":false,"given":"Justyna","family":"Marynowska","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine, Maria Sk\u0142odowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s12672-024-01410-5","article-title":"Advances and prospects in tumor infiltrating lymphocyte therapy","volume":"15","author":"Qiu","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00262-024-03691-9","article-title":"Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy","volume":"73","author":"Choi","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jcyt.2020.07.011","article-title":"Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment","volume":"22","author":"Gannon","year":"2020","journal-title":"Cytotherapy"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00262-018-2211-3","article-title":"Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells","volume":"67","author":"Owens","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcyt.2018.11.004","article-title":"Tumor-infiltrating lymphocytes: Streamlining a complex manufacturing process","volume":"21","author":"Hopewell","year":"2019","journal-title":"Cytotherapy"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lisio, M.A., Fu, L., Goyeneche, A., Gao, Z.H., and Telleria, C. (2019). High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040952"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hong, M.K., and Ding, D.C. (2025). Early Diagnosis of Ovarian Cancer: A Comprehensive Review of the Advances, Challenges, and Future Directions. Diagnostics, 15.","DOI":"10.3390\/diagnostics15040406"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"(2011). The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609\u2013615. Erratum in Nature 2012, 490, 292.","DOI":"10.1038\/nature10166"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1002\/cam4.2243","article-title":"Comprehensive genomic profiling of high-grade serous ovarian carcinoma from Chinese patients identifies co-occurring mutations in the Ras\/Raf pathway with TP53","volume":"8","author":"Zhong","year":"2019","journal-title":"Cancer Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1674-8301(10)60036-X","article-title":"Morphological and molecular basis of ovarian serous carcinoma","volume":"24","author":"Rosen","year":"2010","journal-title":"J. Biomed. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cyto.a.23690","article-title":"Best Practices for Preparing a Single Cell Suspension from Solid Tissues for Flow Cytometry","volume":"95","author":"Reichard","year":"2019","journal-title":"Cytom. A"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jim.2011.07.002","article-title":"Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation","volume":"372","author":"Grange","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1189\/jlb.5TA0814-373","article-title":"An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells","volume":"97","author":"Quatromoni","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13059-019-1830-0","article-title":"Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responses","volume":"20","author":"Campbell","year":"2019","journal-title":"Genome Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"szaf055","DOI":"10.1093\/stcltm\/szaf055","article-title":"Recent advancements in tissue dissociation techniques for cell manufacturing single-cell analysis and downstream processing","volume":"14","author":"Jankelow","year":"2025","journal-title":"Stem Cells Transl. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2007.10.016","article-title":"Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma","volume":"108","author":"Melichar","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imm.13793","article-title":"Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy","volume":"173","author":"Wang","year":"2024","journal-title":"Immunology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100856","DOI":"10.1016\/j.xcrm.2022.100856","article-title":"Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis","volume":"3","author":"Yang","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41588-020-0630-5","article-title":"Unraveling tumor\u2013immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy","volume":"52","author":"Cybulska","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.cell.2018.03.073","article-title":"Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer","volume":"173","author":"Zhang","year":"2018","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2017.07.025","article-title":"Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient","volume":"170","author":"Memon","year":"2017","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41419-026-08429-2","article-title":"The long noncoding RNA AC093895.1 promotes ovarian cancer formation and metastasis through a positive feedback network dependent on the transcription factor SOX4","volume":"17","author":"Huang","year":"2026","journal-title":"Cell Death Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nmeth.4437","article-title":"Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations","volume":"14","author":"Sage","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4172\/2157-7633.1000321","article-title":"Tissue Dissociation Enzymes for Adipose Stromal Vascular Fraction Cell Isolation: A Review","volume":"5","author":"Lockhart","year":"2015","journal-title":"J. Stem Cell Res. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","article-title":"A single-cell landscape of high-grade serous ovarian cancer","volume":"26","author":"Izar","year":"2020","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.1002\/ctm2.500","article-title":"Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma","volume":"11","author":"Hao","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13073-021-00922-x","article-title":"High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: Specific cell subtypes influence survival and determine molecular subtype classification","volume":"13","author":"Olbrecht","year":"2021","journal-title":"Genome Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2011.09.039","article-title":"Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis","volume":"124","author":"Hwang","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00262-019-02402-z","article-title":"Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy","volume":"68","author":"Forget","year":"2019","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/3027\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:30:00Z","timestamp":1790051400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/3027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":31,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18183027"],"URL":"https:\/\/doi.org\/10.3390\/cancers18183027","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}